Valuation: Curiosis, Inc.

Market Cap 127B 94.83M 81.7M 77.36M 70.12M 132M 9.06B 132M 919M 353M 4.61B 356M 348M 14.56B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 109M 81.1K 69.88K 66.17K 59.97K 113K 7.75M 113K 786K 302K 3.94M 305K 298K 12.46M EV / Sales 2026 *
7.06x
EV / Sales 2027 * 4.55x
Free-Float
85.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.12%
1 week-2.80%
Current month-8.66%
1 month-29.88%
3 months-38.97%
6 months-75.86%
Current year-66.00%
1 week 7,990
Extreme 7990
8,790
1 month 7,990
Extreme 7990
11,710
Current year 7,990
Extreme 7990
44,000
1 year 7,990
Extreme 7990
48,200
3 years 7,990
Extreme 7990
48,200
5 years 7,990
Extreme 7990
48,200
10 years 7,990
Extreme 7990
48,200
Manager TitleAgeSince
Chief Executive Officer 55 31/12/2014
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 31/12/2014
Director/Board Member 57 30/11/2016
Director/Board Member 56 30/11/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-2.80% - - 94.83M
+1.10%-0.65%+27.19%+19.36% 225B
-0.19%-3.62%+5.31%-20.72% 141B
+2.41%+0.67%-17.91%+21.95% 130B
-0.28%-10.08%-58.15%-19.21% 62.29B
+1.62%+0.52%-18.80%-14.30% 49.39B
-2.77%-6.15%+8.77%+15.31% 48.63B
+2.66%-2.61%+19.22%+29.53% 41.42B
+1.67%-0.25%+38.24%+52.80% 40.12B
-0.60%-4.41%-19.20%+49.15% 31.23B
Average +0.57%-3.40%-1.70%+14.88% 76.98B
Weighted average by Cap. +0.81%-2.40%+2.79%+10.43%

Financials

2026 *2027 *
Net sales 15.4B 11.49M 9.9M 9.37M 8.5M 15.94M 1.1B 16.02M 111M 42.81M 558M 43.15M 42.2M 1.76B 23.9B 17.83M 15.36M 14.55M 13.18M 24.73M 1.7B 24.86M 173M 66.43M 867M 66.96M 65.49M 2.74B
Net income - -
Net Debt -18.4B -13.73M -11.83M -11.2M -10.15M -19.04M -1.31B -19.14M -133M -51.15M -667M -51.55M -50.42M -2.11B -18.4B -13.73M -11.83M -11.2M -10.15M -19.04M -1.31B -19.14M -133M -51.15M -667M -51.55M -50.42M -2.11B
Logo Curiosis, Inc.
Curiosis Inc is a Korea-based company principally engaged in the development and manufacture of bioresearch equipment, lab automation products, and medical devices. The Company is mainly engaged in the development and manufacture of bio research equipment for implementing lab automation based on bioengineering and automation control technologies, such as automated live-cell imaging systems. Additionally, the Company is engaged in the development and manufacture of lab automation systems including colony picking systems, digital pathology scanners, as well as automated cell concentration and separation systems. The Company is engaged in the manufacture and sales of cell counters and aesthetic medical devices as well.
Employees
-
Date Price Change Volume
11/09/26 ₩8,330.00 +0.12% 119,002
10/09/26 ₩8,320.00 -0.60% 65,690
09/09/26 ₩8,370.00 +1.33% 53,628
08/09/26 ₩8,260.00 -5.71% 112,262
07/09/26 ₩8,760.00 +2.22% 60,255
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A494120 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!